Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,046 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin.
Davies C, Martins D, Dipasquale O, McCutcheon RA, De Micheli A, Ramella-Cravaro V, Provenzani U, Rutigliano G, Cappucciati M, Oliver D, Williams S, Zelaya F, Allen P, Murguia S, Taylor D, Shergill S, Morrison P, McGuire P, Paloyelis Y, Fusar-Poli P. Davies C, et al. Among authors: morrison p. Mol Psychiatry. 2024 Jan 19. doi: 10.1038/s41380-024-02406-x. Online ahead of print. Mol Psychiatry. 2024. PMID: 38243074
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.
Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Antoniades M, Modinos G, Oliver D, Stahl D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, McGuire P, Fusar-Poli P. Davies C, et al. Among authors: morrison p. Neuropsychopharmacology. 2019 Jun;44(7):1300-1309. doi: 10.1038/s41386-018-0311-6. Epub 2019 Jan 9. Neuropsychopharmacology. 2019. PMID: 30626906 Free PMC article. Clinical Trial.
Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
Davies C, Rutigliano G, De Micheli A, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, Scutt E, Paloyelis Y, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Lythgoe DJ, McGuire P, Fusar-Poli P. Davies C, et al. Among authors: morrison p. Eur Neuropsychopharmacol. 2019 May;29(5):601-615. doi: 10.1016/j.euroneuro.2019.03.008. Epub 2019 Mar 28. Eur Neuropsychopharmacol. 2019. PMID: 30928180
Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis.
Schmidt A, Davies C, Paloyelis Y, Meyer N, De Micheli A, Ramella-Cravaro V, Provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Borgwardt S, Yamasue H, McGuire P, Fusar-Poli P. Schmidt A, et al. Among authors: morrison p. Transl Psychiatry. 2020 Jun 22;10(1):203. doi: 10.1038/s41398-020-00885-4. Transl Psychiatry. 2020. PMID: 32572020 Free PMC article. Clinical Trial.
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O' Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Bhattacharyya S, et al. Among authors: morrison pd. Neuropsychopharmacology. 2010 Feb;35(3):764-74. doi: 10.1038/npp.2009.184. Epub 2009 Nov 18. Neuropsychopharmacology. 2010. PMID: 19924114 Free PMC article. Clinical Trial.
1,046 results